Top Tweets for #AMLmatters
Join us @discmasterbone at 5pm discuss, The Role of the Youth in Anti-Money Laundering and Counter Financing Terrorism(AML/CFT) on @WestFM9751
#AMLmatters #Financialcrime #economicstability
@TettehLovia
@nccegh @fincrimecomp
Important new work on what patients weigh and value in treatment decision making in #AML. Shows the need for #shareddecisionmaking in acute leukemia care. Nicely done @danielrich21! #leusm #AMLmatters
Now out in @CEBP_AACR. Age at Diagnosis and Patient Preferences for Treatment Outcomes in AML: A Discrete Choice Experiment to Explore Meaningful Benefits. #AML #leusm #patientexperience @UNC_Lineberger @corp_UNC @AACR @jfpbridges
https://t.co/mB07UcmM4K
Comments to follow 1/
@ASH_hematology is working on new guidelines for the management of #AML in older adults. A draft is now posted for public review and comment. Consider adding your feedback as the ramp-up to #ASH19 begins: https://t.co/WWRKDOqkJT #ASHGuidelines #leusm #leukemia #AMLmatters
Nearly half of older Americans with acute myeloid leukemia don't receive treatment. Amid recent therapeutic breakthroughs, this is a travesty. Learn why, from @DukeCancer #leukemia faculty, on @Medscape TV: https://t.co/J5jG0VFYbC #AMLmatters @ASH_hematology @DukeHMCT #leusm
Fascinating new findings regarding the feasibility of using "circulating tumor DNA" for prognostication among patients with AML or MDS after allogeneic stem cell transplant; looks like it could be a very promising tool: https://t.co/vfC6YuYjlK #leusm #bmtsm #leukemia #AMLmatters
Great new review article on the role of #transplantation in management of younger patients with #AML. Should be required reading for heme/onc fellows or anyone managing AML in the community. Thanks @JOP_ASCO! #leusm #bmtsm #leukemia #AMLmatters https://t.co/trNHRicdMM
More exciting news in the #AML world today: #ivosidenib was just approved by @US_FDA for first-line treatment in patients with IDH1 mutation who are age 75 and older, or with comorbidities precluding intensive therapy: https://t.co/oim4KhmpAk #leusm #leukemia #AMLmatters
This is a huge #patientexperience issue in need of a solution! Countless beeps interrupt patients' sleep, and too many meaningless beeps creates "alarm fatigue" for staff, whereby an important alarm can go ignored for too long #leusm #leukemia #hpm #pallonc #AMLmatters
For our patients going through 30+ day AML induction or long stays for allo transplant, the cacophony of noise from hospital alarms is exhausting: “an average of 350 alarms per patient per day...99% false”. Biggest offenders: IV pumps & telemetry/pulse ox. https://t.co/2RsH7eu70B
There's much to learn about the #leukemia #patientexperience. Interviews with #AML patients highlight unmet needs in: symptom management, psychological well-being, uncertainty mgt, opportunities for integrated #palliative care: https://t.co/R6QFHWqkTu #pallonc #leusm #AMLmatters
New data is questioning the old paradigm of low-dose chemo / hypomethylating therapies as just palliative options for #AML treatment. Some patients do achieve complete remission, and it can be a bridge to transplant: https://t.co/jFaM0i4C7a #leukemia #AMLmatters #leusm #ASH17
#Ivosidenib appears to be a promising, emerging treatment option for #AML with #IDH1 mutation. Will this be the next new drug to be approved for #AML? Exciting to see such progress in personalized, targeted therapy for #leukemia! https://t.co/3yR2IuJyhn #AMLmatters
Minimal residual disease assessment in #AML is still not ready for prime time; need to figure out how to balance the promise and possibilities with challenges relating to how/when to test, and how to use the results. Great summary here: https://t.co/z7Qv0g7EZn #leusm #AMLmatters
Achieving remission is an important outcome in #AML; remission status correlates with markedly better quality of life, fewer symptoms, and less psychological distress: https://t.co/XaCFsZSx3L #AMLmatters #leusm #pallonc #hpm #patientexperience @KNOW_AML @ASH_hematology
Don't forget to attend this week's free #AMLMATTERS summit in Philadelphia to earn CME credit https://t.co/k2ZIEtDv4B
Kudos to @ASH_hematology @OncologyNursing @BeTheMatch @FranceFound on great #AMLMatters summit today in Durham NC! @DukeCancer #leusm
Don't miss next week's free #AMLMATTERS summit in Philadelphia to earn CME credit https://t.co/bXhgZNZHDz
Don't miss the free #AMLMATTERS summit in Philadelphia this month to earn CME https://t.co/jtoxEibAzI
Don't miss the free #AMLMATTERS summit in Philadelphia next month to earn CME https://t.co/vcpErF8pYS
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.9M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers